DPDoctor's PassportEducation
Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.
RapidMLAMSRAFoundationMRCS

Reticulocytes, haemolysis and bone-marrow response

Essential points for quick revision.

!
Escalate

Rapid haemoglobin fall with shock, chest pain, hypoxia, haemoglobinuria, severe hyperkalaemia, transfusion-reaction symptoms, microangiopathic haemolysis with thrombocytopenia, or haemolysis during pregnancy requires immediate stabilisation and specialist assessment. Take diagnostic samples promptly, but do not delay treatment of circulatory or organ compromise.

Synopsis

Use the absolute reticulocyte response and a coherent haemolysis profile to distinguish red-cell underproduction, loss and destruction, then select immune, membrane, enzyme or mechanical testing.

  • Use the absolute reticulocyte count, not the percentage alone. A percentage can appear high simply because the circulating red-cell denominator is low.
  • Ask whether the response is appropriate for the depth and duration of anaemia. Reticulocytes take time to rise, and severe iron, B12 or folate deficiency can limit a response despite haemolysis.
  • A typical haemolysis pattern combines raised indirect bilirubin and LDH, low haptoglobin, reticulocytosis and film change, but inflammation, liver disease, ineffective erythropoiesis and recent transfusion can alter individual markers.

Key red flags

Intravascular haemolysis

Back or abdominal pain, dark urine, haemoglobinaemia, marked haptoglobin depletion and acute kidney or potassium disturbance suggest red-cell destruction within the circulation.

Investigation priorities

01
Absolute reticulocyte countFirst step

Measure effective marrow erythroid output in relation to the anaemia.

Management branches

ConfirmProve haemolysis and grade urgency

Haemoglobin is falling or jaundice, dark urine, splenomegaly or a regenerative count suggests red-cell destruction.

  1. First-line testing is FBC, absolute reticulocytes, film, bilirubin fractions, LDH, haptoglobin, DAT, renal profile and urinalysis, alongside observations and a bleeding assessment.
  2. Check prior counts, transfusion and medicine timing, liver disease, infection, pregnancy and prosthetic valves; an alternative diagnosis is blood loss when reticulocytosis occurs without a convincing destructive profile.
ClassifySeparate immune from non-immune destruction

The haemolysis profile is supported and the patient is physiologically stable enough for cause-directed testing.

Open full textbook Answer 2 questions
Sources and review status6 sources · checked 27 Aug 2026 · clinical review pending
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 27 Aug 2026; clinical approval remains outstanding.

Authoring stateRapid draftClinical stateAwaiting reviewJurisdictionUnited Kingdom